CDH1 and neoplasm: Additionally, treatment with endocytosis inhibitors demonstrated that while the binding of FadA to E-cadherin and the phosphorylation of E-cadherin were unaffected, endocytosis was blocked, indicating that FadA-mediated tumor promotion and inflammation are dependent on both membrane binding and the endocytosis process (Bryant and Stow, 2004).